The continuing uncertainty about cancer risk in inflammatory bowel disease.
about
Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management.Clonal evolution of colorectal cancer in IBD.MTG16 is a tumor suppressor in colitis-associated carcinoma.Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014.From Colitis to Cancer: An Evolutionary Trajectory That Merges Maths and Biology
P2860
The continuing uncertainty about cancer risk in inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The continuing uncertainty about cancer risk in inflammatory bowel disease.
@en
The continuing uncertainty about cancer risk in inflammatory bowel disease.
@nl
type
label
The continuing uncertainty about cancer risk in inflammatory bowel disease.
@en
The continuing uncertainty about cancer risk in inflammatory bowel disease.
@nl
prefLabel
The continuing uncertainty about cancer risk in inflammatory bowel disease.
@en
The continuing uncertainty about cancer risk in inflammatory bowel disease.
@nl
P2093
P2860
P50
P1433
P1476
The continuing uncertainty about cancer risk in inflammatory bowel disease.
@en
P2093
Mette Kalager
Michael Bretthauer
Miguel A Hernán
P2860
P304
P356
10.1136/GUTJNL-2015-311003
P407
P577
2016-03-23T00:00:00Z